SCHEMBL2044547

SCHEMBL2044547

O=C(O)CCC(=O)OC(CO)CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
MAPK1 P28482 3/20 0.47
PRKCA P17252 2/20 0.41
PRKCE Q02156 2/20 0.41
PRKCQ Q04759 2/20 0.41
PRKCD Q05655 2/20 0.41
FAAH O00519 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
EGLN1 Q9GZT9 2/20 0.36
KDM6B O15054 1/20 0.36
KDM5C P41229 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
KDM2A Q9Y2K7 1/20 0.36
LMNA P02545 2/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
CYP1A2 P05177 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8398545 0.89 MAPT (0.58) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL542358 0.87 MAPT (0.53) MAPTMAPK1PRKCAPRKCEPRKCQ
Water SCHEMBL9474377 0.85 MAPT (0.52) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL5026886 0.78 PRKCA (0.60) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL13901278 0.78 MAPT (0.61) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL1686207 0.76 MAPT (0.36) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL9190664 0.76 GABRP (0.43) FAAHCNR1CNR2EGLN1KDM6B
SCHEMBL23694892 0.76 PHF8 (0.46) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL23693964 0.76 PHF8 (0.46) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL23694900 0.76 PHF8 (0.46) MAPTMAPK1PRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964696-B2 Chain extenders POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-06-21 US claimed
US-20090175921-A1 Chain Extenders POLYNOVO BIOMATERIALS PTY LIMITED 2009-07-09 US claimed
EP-1945690-A1 CHAIN EXTENDERS Polynovo Biomaterials Pty Limited (AU) 2008-07-23 EP claimed
WO-2007033418-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2007-03-29 WO claimed
US-20150105530-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LTD (AU) 2015-04-16 US disclosed
EP-2195361-A1 HIGH MODULUS POLYURETHANE AND POLYURETHANE/UREA COMPOSITIONS Polynovo Biomaterials Limited (AU) 2010-06-16 EP disclosed
WO-2009043099-A1 HIGH MODULUS POLYURETHANE AND POLYURETHANE/UREA COMPOSITIONS POLYNOVO BIOMATERIALS LIMITED (AU) 2009-04-09 WO disclosed
EP-1945690-A1 CHAIN EXTENDERS Polynovo Biomaterials Pty Limited (AU) 2008-07-23 EP disclosed
WO-2007033418-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090175921-A1 Chain Extenders UMPS, PUF60, SMC1A MAPT 956/4885MAPK1 1706/4885PRKCA 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.